FindTrial
Sign In

Transcranial Direct Current Stimulation associated with ReST for speech disorders: a randomized clinical trial

Transcranial Direct Current Stimulation associated with the ReST Method on the Treatment of Motor Speech Disorders: A Randomized Clinical Trial - ReST Rapid Silable Transition Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9f5f4yr
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-12-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Articulation Disorders

Interventions

This is a randomized, controlled, double-blind clinical study, with a child population = Study 1 and an adult population = Study 2. Experimental Group 1 (EG1): 15 children with Motor Speech Disorder w
E02.331.750

Sponsors

Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA
Lead Sponsor
Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA
Collaborator

Eligibility

Age
5 Years to No maximum

Inclusion criteria

Inclusion criteria: Study 1: Children of both sexes; ages 5 to 12 years and 11 months; speech-language pathology diagnosis of Motor Speech Delay, Childhood Apraxia of Speech, Developmental Dysarthria, or Childhood Apraxia of Speech associated with Developmental Dysarthria. Study 2: Adults of both sexes; ages 18 and older; speech-language pathology diagnosis of Apraxia or Dysarthria

Exclusion criteria

Exclusion criteria: Study 1: neurological diagnosis that constitutes the etiological cause of speech motor alterations such as cerebral palsy, syndromes, intellectual disability; craniofacial anomalies such as cleft lip and palate; metal implants in the skull; brain diseases such as tumors; skin diseases; failure in hearing screening performed with Transient Evoked Otoacoustic Emissions; concomitant speech-language pathology intervention; previous application of Transcranial Direct Current Stimulation. Study 2: oral comprehension deficits; failure in hearing screening performed with Transient Evoked Otoacoustic Emissions; craniofacial deformity reported or observed during the evaluation; neurological and/or psychiatric disease other than stroke; concomitant speech-language pathology intervention; previous application of Transcranial Direct Current Stimulation

Design outcomes

Primary

MeasureTime frame
Expected outcome: To evaluate speech intelligibility verified by the Percentage of Correct Consonants - PCC method and the Verbal Praxis Assessment Protocol - ProAPV at the beginning of the study and at the end of the study—

Secondary

MeasureTime frame
No secondary outcomes are expected.—

Countries

Brazil

Contacts

Public ContactAnanda Pereira

Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA

ananda.pereira@ufcspa.edu.br+55(51) 3303-8700

Outcome results

None listed

Source: REBEC (via WHO ICTRP)